Suction Consumables, Wound Drainage, Autologous Blood Systems and Accessories
Estimated value
£92.0m
Awarded value
—
Suppliers
0
Lots
4
Published
10 Feb 2023
This is a preliminary market engagement notice
Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.
Description
The scope of the framework is to cover the supply of products and their associated consumables and accessories for suction consumables, wound drainage post-operative and intra-operative autologous blood system products. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £21,000,000 to £23,000,000 in the first year of this framework agreement; however, this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. The estimated value of the total framework agreement term (including any extension options) of between £84,000,000 to £92,000,000.
Scope
- Reference
- ocds-h6vhtk-03a4d8
- Total value
- £92,000,000 excluding VAT
- Commercial tool
- Standalone contract
- Main category
- goods
- CPV classifications
- 33100000331412003314124033141600331620003317000033172000331900003317100033194000
- Contract locations
- UK
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Supply Chain Resilience | 25 | quality | — |
| Sales, Service and Quality | 20 | quality | — |
| Training and Education Value Add Programmes | 15 | quality | — |
| Social Value | 10 | quality | — |
| — | 30 | price | — |
Lots · 4 total
Divisions of the contract. Each lot can be awarded separately.
| Lot | Title | Est. value | Status |
|---|---|---|---|
| 1 | Suction Consumables and Accessories | £120.0m | planned |
| 2 | Manual and Powered Suction Devices, Machines, Suction Canisters and Accessories | £30.0m | planned |
| 3 | Surgical Drains, Chest/Thoracic Drainage and Accessories | £32.0m | planned |
| 4 | Autologous Blood System Products and Purchase Plans | £6.4m | planned |